Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients is a paper indexed in PICO Portal from OpenAlex.
How many citations does Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients have?
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients has 17 citations in the OpenAlex counts PICO Portal stores.
When was Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients published?
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients has 2018 year in the PICO Portal index.
What is the open-access status of Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients?
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients has gold oa status in the PICO Portal index.
What is the DOI of Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients?
The DOI for Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients is on the source record.
What is the PMID of Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients?
The PMID for Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients is on the source record.
What is the OpenAlex record for Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients?
The OpenAlex for Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients is on the source record.